All Stories

  1. Coenzyme Q10 for Enhancing Physical Activity and Extending the Human Life Cycle
  2. Perspectives on Iron Deficiency as a Cause of Human Disease in Global Public Health
  3. Early-Life Lead Exposure: Risks and Neurotoxic Consequences
  4. Berberine: Pharmacological Features in Health, Disease and Aging
  5. Metal Toxicity and Speciation: A Review
  6. A Comprehensive Review on Oxysterols and Related Diseases
  7. The essential metals for humans: A brief overview
  8. Medical Uses of Silver: History, Myths, and Scientific Evidence
  9. A new tripodal kojic acid derivative for iron sequestration: Synthesis, protonation, complex formation studies with Fe3+, Al3+, Cu2+ and Zn2+, and in vivo bioassays
  10. New strong extrafunctionalizable tris(3,4-HP) and bis(3,4-HP) metal sequestering agents: synthesis, solution and in vivo metal chelation
  11. Equilibrium studies of new bis-hydroxypyrone derivatives with Fe3+, Al3+, Cu2+ and Zn2+
  12. Mn(II) interaction with proteins responsible for ROS response and defense in DR
  13. Tungsten or Wolfram: Friend or Foe?
  14. The Intriguing Potential of “Minor” Noble Metals: Emerging Trends and New Applications
  15. Noble Metals in Pharmaceuticals: Applications and Limitations
  16. Looking at new ligands for chelation therapy
  17. A new tripodal-3-hydroxy-4-pyridinone for iron and aluminium sequestration: synthesis, complexation and in vivo studies
  18. para-Aminosalicylic acid in the treatment of manganese toxicity. Complexation of Mn2+ with 4-amino-2-hydroxybenzoic acid and its N-acetylated metabolite
  19. Ni(II) interaction with a peptide model of the human TLR4 ectodomain
  20. Interaction of a chelating agent, 5-hydroxy-2-(hydroxymethyl)pyridin-4(1 H )-one, with Al(III), Cu(II) and Zn(II) ions
  21. Complex formation equilibria of Cu2+ and Zn2+ with Irbesartan and Losartan
  22. Toxicity of Nanoparticles: Etiology and Mechanisms
  23. Joint 16th International Symposium on Trace Elements in Man and Animals (TEMA-16), 12th Conference of the International Society for Trace Element Research in Humans (ISTERH 2017) and 13th Conference of the Nordic Trace Element Society (NTES 2017)
  24. Chemical features of in use and in progress chelators for iron overload
  25. Silver coordination compounds: A new horizon in medicine
  26. Manganese binding to antioxidant peptides involved in extreme radiation resistance in Deinococcus radiodurans
  27. Competition between Cd(II) and other divalent transition metal ions during complex formation with amino acids, peptides, and chelating agents
  28. Fluoroquinolones: A micro-species equilibrium in the protonation of amphoteric compounds
  29. Coordination Environment of Cu(II) Ions Bound to N-Terminal Peptide Fragments of Angiogenin Protein
  30. Substituent effects on ionization constants as a predictive tool of coordinating ability
  31. Immune compatible cystine-functionalized superparamagnetic iron oxide nanoparticles as vascular contrast agents in ultrasonography
  32. Manganism and Parkinson's disease: Mn(ii) and Zn(ii) interaction with a 30-amino acid fragment
  33. Hydroxypyridinones with enhanced iron chelating properties. Synthesis, characterization and in vivo tests of 5-hydroxy-2-(hydroxymethyl)pyridine-4(1H)-one
  34. Zinc(II) and copper(II) complexes with hydroxypyrone iron chelators
  35. Tungsten-induced carcinogenesis in human bronchial epithelial cells
  36. An NMR study on the 6,6′-(2-(diethylamino)ethylazanediyl)bis(methylene)bis(5-hydroxy-2-hydroxymethyl-4H-pyran-4-one) interaction with AlIII and ZnII ions
  37. Noble metals in medicine: Latest advances
  38. Kill or cure: Misuse of chelation therapy for human diseases
  39. A new bis-3-hydroxy-4-pyrone as a potential therapeutic iron chelating agent. Effect of connecting and side chains on the complex structures and metal ion selectivity
  40. Nutritional Iron Deficiency: The Role of Oral Iron Supplementation
  41. Toxicity of Nanoparticles
  42. Ni(ii) binding to the 429–460 peptide fragment from human Toll like receptor (hTLR4): a crucial role for nickel-induced contact allergy?
  43. Interaction of Cu(II) and Ni(II) with Ypk9 Protein FragmentviaNMR Studies
  44. The Involvement of Amino Acid Side Chains in Shielding the Nickel Coordination Site: An NMR Study
  45. Nickel binding sites in histone proteins: Spectroscopic and structural characterization
  46. Interaction of divalent cations with peptide fragments from Parkinson's disease genes
  47. Manganese and cobalt binding in a multi-histidinic fragment
  48. Mn(ii) and Zn(ii) interactions with peptide fragments from Parkinson's disease genes
  49. NMR studies of zinc binding in a multi-histidinic peptide fragment
  50. Nickel binding to histone H4
  51. Metal-chelating properties of carvedilol: an antihypertensive drug with antioxidant activity
  52. Copper and nickel binding in multi-histidinic peptide fragments
  53. An NMR study on nickel binding sites in Cap43 protein fragments
  54. Copper(ii) binding to Cap43 protein fragments
  55. Paramagnetism-Based NMR Restraints Provide Maximum Allowed Probabilities for the Different Conformations of Partially Independent Protein Domains
  56. Multidimensional NMR spectroscopy for the study of histone H4–Ni(ii) interaction
  57. Nickel(II) binding to Cap43 protein fragments
  58. Experimentally exploring the conformational space sampled by domain reorientation in calmodulin
  59. The binding of Ni(ii) and Cu(ii) with the N-terminal tail of the histone H4